Alliance for Clinical Trials in Oncology

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

Phase 2Recruiting164 people19 Dec 2025clinicaltrials.gov

Family Communications After Genetic Testing

No phaseRecruiting4,186 people27 Aug 2025clinicaltrials.gov

Distance-Based Exercise to Preserve Function and Prevent Disability

No phaseRecruiting104 people11 Jul 2025clinicaltrials.gov

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Phase 3Recruiting228 people28 May 2025clinicaltrials.gov

NCT06671912

Phase 3Suspended1,556 people4 Nov 2024clinicaltrials.gov

NCT06632327

Phase 3Active, not recruiting37 people9 Oct 2024clinicaltrials.gov

Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma

Phase 1/2Suspended88 people30 Jan 2024clinicaltrials.gov

NCT06205485

CollaboratorPhase 3Recruiting250 people16 Jan 2024clinicaltrials.gov

NCT06115499

Phase 2/3Active, not recruiting10 people3 Nov 2023clinicaltrials.gov

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Phase 2Recruiting146 people6 Jan 2023clinicaltrials.gov

NCT05303792

Phase 2Active, not recruiting68 people31 Mar 2022clinicaltrials.gov

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Phase 3Recruiting600 people17 Aug 2021clinicaltrials.gov

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

Phase 2Recruiting170 people17 Mar 2021clinicaltrials.gov

Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation

Phase 3Active, not recruiting300 people15 Jan 2021clinicaltrials.gov

NCT03839940

Phase 3Terminated39 people15 Feb 2019clinicaltrials.gov

NCT03609216

Phase 2Active, not recruiting237 people1 Aug 2018clinicaltrials.gov

NCT03578081

Phase 3Completed690 people5 Jul 2018clinicaltrials.gov

NCT03550391

CollaboratorPhase 3Recruiting206 people8 Jun 2018clinicaltrials.gov

NCT03488693

CollaboratorPhase 3Active, not recruiting2,138 people5 Apr 2018clinicaltrials.gov

NCT03414970

Phase 3Active, not recruiting898 people30 Jan 2018clinicaltrials.gov